Third-Party Fundraising (Post–Balance Date Inflow)Disclosed in the Report:“Renergen has entered into an exclusive arrangement to negotiate a transaction with a third party. As part of those negotiations, Renergen has received an initial inflow of US$10 million — US$5 million received on 1 April 2025 and the balance on 8 April 2025.
To the extent the negotiations proceed as planned, additional funding will be extended to Renergen.” Key DetailsTiming: Occurred after the 28 Feb 2025 balance date, so it is not reflected in the financials but is significant as a subsequent event.Source: Unnamed third party (possibly strategic or financial investor)Structure: Not specified — could be debt, convertible instrument, equity, or hybridAmount: US$10 million (~R190 million+ at current FX rates)Further Upside:
The agreement contemplates additional funding, depending on how negotiations proceed SignificanceThis inflow is critical to liquidity and compliance with
FC waiver conditions (requiring equity injection and DSRA remediation by 31 May 2025)Working capital and project funding (Phase 1C)It may also signal pending strategic investment, merger, or acquisition Strategic ImplicationsRenergen is actively negotiating a broader deal — this US$10M is likely a preliminary tranche or earnest moneyDepending on how this unfolds, it could
e-risk the current funding gapLead to a strategic partner or buyer.
(20min delay)